Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

76.09
Delayed Data
As of 4:00pm ET
 +0.21 / +0.28%
Today’s Change
63.76
Today|||52-Week Range
86.27
+6.26%
Year-to-Date
GILD Regular Dividend: GILD will begin trading ex-dividend on 12/14/17 with a $0.52 dividend payable to shareholders of record as of 12/15/17.
Jim Simons: Pioneer Quant Manager
2:55pm / GuruFocus News - Paid Partner Content
Here's Why Bluebird Bio (BLUE) Stock Skyrocketed Today
Dec 11 / Zacks.com - Paid Partner Content
4 Signs the Bull Market in Stocks Remains Incredibly Strong
11:12am / TheStreet.com - Paid Partner Content
Key Feature in Marketks
Dec 11 / TheStreet.com - Paid Partner Content
Bluebird's Shares Jump on Strong Data for CAR-T Therapy
10:32am / Zacks.com - Paid Partner Content
Company News For Dec 11, 2017
Dec 11 / Zacks.com - Paid Partner Content
Gilead (GILD) Posts Updated Data on CAR-T Therapy Yescarta
Dec 11 / Zacks.com - Paid Partner Content
3 Stocks in Focus as Biotech M&A Hopes for 2018 Rise
Dec 11 / Zacks.com - Paid Partner Content
Novartis Reports Updated Results from Kymriah's JULIET Study
Dec 11 / Zacks.com - Paid Partner Content
Gilead Sciences to Acquire Cell Design Labs for $567 Million
Dec 08 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close75.88
Today’s open76.05
Day’s range74.25 - 76.16
Volume9,276,496
Average volume (3 months)8,991,068
Market cap$96.9B
Data as of 4:00pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)-16.54%
Earnings growth (this year)-24.74%
Earnings growth (next 5 years)-6.55%
Revenue growth (last year)-5.37%
P/E ratio8.7
Price/Sales3.21
Price/Book5.15

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-0.57-0.32%
BIIBBiogen-0.28-0.09%
ILMNIllumina Inc-1.47-0.69%
----
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateFebruary 6, 2018
EPS forecast (this quarter)$1.67
Annual revenue (last year)$30.3B
Annual profit (last year)$13.5B
Net profit margin44.53%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Operating Officer
Kevin B. Young
Corporate headquarters
Foster City, California

Forecasts